Neurologists should retain diagnostic and therapeutic management of migraines

Neurol Neurochir Pol. 2023;57(5):452-453. doi: 10.5603/pjnns.96686. Epub 2023 Sep 14.

Author

Josef Finsterer¹

Affiliation

¹ Neurology and Neurophysiology Centre, Vienna, Austria. fifigs1@yahoo.de.

PMID: 37706667
DOI: 10.5603/pjnns.96686

No abstract available

Keywords: aesthetic medicine professionals; botulinum toxin; headache; migraine.

Publication types

Comment

MeSH terms

Botulinum Toxins, Type A* / therapeutic use
Humans
Migraine Disorders* / drug therapy
Migraine Disorders* / therapy
Neurologists
Neuromuscular Agents* / therapeutic use

Substances

Botulinum Toxins, Type A
Neuromuscular Agents